marketsgonewild

Get Your Boobs Ready: Verano’s 2nd Annual Donation Drive for Breast Cancer Awareness Month is Here!

Dispensary-led Punch Card Campaign in Support of Breast Cancer Awareness Verano Launches Second Annual Donation Effort Imagine this: you walk into your favorite cannabis dispensary, ready to pick up your favorite products, and you’re handed a punch card. But this isn’t just any punch card – it’s a punch card with a purpose. Verano Holdings…

Read More

Unlocking the Future: Smart Drug Delivery Systems Market Set to Soar with a 15.2% Growth Rate, According to TMR Study

Welcome to the Future of Healthcare! Smart Drug Delivery Systems Revolutionizing Patient Care The connected autoinjectors category is anticipated to expand rapidly as more companies enter the market with connected autoinjectors enhancing patient satisfaction Wilmington, Delaware, United States, Sept. 29, 2022 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – In 2021, the value of global…

Read More

Nine Organizations Receive Advanced NCQA Health Equity Accreditation: Celebrating a Milestone in Promoting Inclusive Healthcare

Health Equity Accreditation Plus Builds on Core Equity Standards, Distinguishes High-Level Organizations and Proves Feasibility of Enhanced Standards WASHINGTON, Sept. 28, 2022 (GLOBE NEWSWIRE) — The National Committee for Quality Assurance (NCQA) today announced that nine health care organizations have earned accreditation in the first cohort of the NCQA Health Equity Accreditation Plus program. Advancing…

Read More

Attention Investors: Don’t Miss the Deadline for Fulgent Genetics Shareholder Alert – Take Action Now!

FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. New Orleans, Sept. 27, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a…

Read More

Attention Shareholders: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADC Therapeutics SA (ADCT)

Investigation into ADC Therapeutics SA September 27, 2022 New York, NY Attention all investors! Pomerantz LLP is currently looking into claims regarding ADC Therapeutics SA (“ADC” or the “Company”). If you are a shareholder of ADC (NYSE: ADCT), please reach out to Robert S. Willoughby at [email protected] or call 888-476-6529, ext. 7980. The investigation is…

Read More